Company Legal Name
Latest Valuation
Founded Year
Headquarter
Lila Sciences operates an AI platform that combines generative artificial intelligence with autonomous laboratory systems to accelerate scientific discovery across life sciences, chemical research, and materials development. Founded in 2023 and headquartered in Cambridge, the company has rapidly established itself as a pioneering force in AI-driven scientific research automation. The platform enables researchers to conduct experiments and generate insights at unprecedented speed and scale by integrating advanced machine learning algorithms with robotic laboratory infrastructure. Having achieved a $1.3 billion valuation within its first year, Lila Sciences continues expanding its autonomous research capabilities to transform traditional scientific methodologies.
Revenue & Revenue Growth Share
Revenue
Revenue Growth
Available in most regions; subject to local regulations.
Open to non-accredited investors with KYC/AML compliance. U.S. investors must meet SEC requirements.
$10 per token, enabling fractionalized access to Pre-IPO shares.
Mandatory identity (KYC) and proof of funds checks.
Variable, applied to investment amounts.
Charged on realized profits.
Tokens may be locked for 6–12 months; resale depends on secondary market liquidity.
Prices reflect past funding rounds, not guaranteed future value.
Biotech depends on regulatory approvals; fintech faces evolving digital asset rules.
Blockchain or custodian issues could delay transfers or verification.
Changing laws may affect tradability or taxation.
